A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab.

Furui, Yu; Kurata, Takashi; Komori, Kazutoshi; Uchida, Eriko; Miyairi, Yosuke; Chiba, Akihiro; Ogiso, Yoshifumi; Sakashita, Kazuo.

Afiliação

Furui Y; Department of Hematology and Oncology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8205 Japan.
Kurata T; Department of Hematology and Oncology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8205 Japan.
Komori K; Department of Hematology and Oncology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8205 Japan.
Uchida E; Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Miyairi Y; Department of Neurosurgery, Nagano Children's Hospital, Azumino, Japan.
Chiba A; Department of Neurosurgery, Nagano Children's Hospital, Azumino, Japan.
Ogiso Y; Department of Clinical Pathology, Nagano Children's Hospital, Azumino, Japan.
Sakashita K; Department of Hematology and Oncology, Nagano Children's Hospital, 3100 Toyoshina, Azumino, Nagano, 399-8205 Japan.

Int Cancer Conf J ; 11(4): 280-285, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36186222